For exploring the mechanism of elevated serum IL-13 levels in SSc patients, Medsger et al. [182,183] found that IL-13 was not only excessively produced by peripheral CD8+T cells but GATA-3 upregulation in these CD8+ T cells can become a biomarker of immune dysfunction in SSc patients. This evidence concerns the gene CD8A and systemic sclerosis.